ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 820,00
1,51%
DAX
18 518,03
-0,44%
Brent Oil
83,32
-1,21%
Bitcoin
64 412,61
-0,67%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
05/05/201514h30Business WireTeva gibt weitere Einzelheiten zur geplanten Übernahme von Mylan bekanntNYSE:TEVATeva Pharmaceutical Industries Ltd
05/05/201513h23The Motley FoolWarren Buffett's Portfolio: Pharmaceutical Companies the Oracle of Omaha Should LoveNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201514h46Business Wireテバがマイランの取締役に書簡を送付NYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201514h04The Motley FoolWhat's It Worth? Merger Mania Means Generic-Drug Makers DisagreeNYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201514h55Analyst Ratings NetworkTeva Pharmaceutical Industries Stock Rating Reaffirmed by Cowen and Company (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201502h08Dow Jones NewsDrug Maker Mylan Sues Law Firm Kirkland & EllisNYSE:TEVATeva Pharmaceutical Industries Ltd.
01/05/201523h54Business WireTeva envoie une lettre au conseil d'administration de MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
01/05/201516h43Business WireTeva wendet sich mit Brief an das Board von MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
01/05/201514h34Business Wireテバ、1株当たり82.00ドルでの現金と株式によるマイラン買収提案を再確認NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201519h47The Motley FoolTeva Pharmaceutical Industries Ltd Posts Solid Quarter, Stays Mum on MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201517h47Business WireTeva invia lettera al CdA di MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201517h15The Motley FoolTeva Pharmaceutical Industries Ltd. Posts Strong First-Quarter Earnings: Is the Stock Now a Buy?NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201515h37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201514h48Business Wireテバ、現金と株式交換による1株当たり82.00ドルでのマイラン買収を提案NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201514h30Dow Jones NewsTeva Raises Guidance as Generic-Medicine Segment GrowsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201513h00Business WireTeva Reports First Quarter 2015 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201522h13Business WireTeva Sends Letter to Mylan BoardNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201517h43Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 Billion -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
29/04/201516h20Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd.
29/04/201516h17Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 Billion--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201513h21Analyst Ratings NetworkTeva Pharmaceutical Industries Upgraded at Standpoint Research (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201521h21Business WireTeva Launches Generic Abilify® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201518h21Business WireTeva bekräftigt sein Engagement für die Übernahme von Mylan für 82,00 US-Dollar je Aktie in bar und in Form von Aktien de...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201514h30Business WireTeva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201510h46Business WireTeva ripete l'impegno nei confronti dell'acquisizione di Mylan in contanti e titoli a $82,00 per azioneNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201505h35Business WireTeva réitère son engagement au regard de l'acquisition en numéraire et en actions de Mylan au prix de 82,00 dollars US par...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201504h05Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion Bid--4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
28/04/201500h31Dow Jones NewsADR Shares End Mixed; Teva DeclinesNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/04/201523h10Dow Jones NewsU.S. Stocks End LowerNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/04/201521h26Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion Bid--3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

BIT
NSCIT5380976
Magnolia
BIT
F21426
Vontobel Financial Produ...
BIT
P20L23
NLBNPIT20L23 20991231 10...
BIT
P224S3
NLBNPIT224S3 20991231 16...
AQSE
MLVN.GB
Malvern
BIT
F18867
Vontobel Financial Produ...
BIT
UB30FR
UniCredit Bank
BIT
PA1846
Bnp Paribas Issuance
BIT
P20PD3
NLBNPIT20PD3 20991231 14...
LSE
RSVL
Russell Value
BIT
UC2X0E
Unicredit Bank
BIT
W68AR9
UBS
NASDAQ
FGBIP
First Guaranty Bancshares
LSE
AUAD
Ubsetf Auad
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés